LINEA TROVATA BIOCONSTRUCT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LINEA TROVATA BIOCONSTRUCT
Largest movements
- Receivables within one year -€12,028
down €12,028 (-97.9%), from €12,284 to €256
of which Trade receivables: -€11,929
- Cash +€11,838
up €11,838 (+4,470%), from €265 to €12,103
mainly Depreciation (+€15,652) and Receivables within one year (+€12,028)
- Tangible fixed assets -€10,543
down €10,543 (-1.9%), from €541,970 to €531,427
- Profit (loss) carried forward -€14,867
down €14,867 (-7.0%), from -€212,164 to -€227,030
- Turnover -€56,051
no longer reported in 2025 (was €56,051)
- Gross operating margin -€40,096
down €40,096 (-91.5%), from €43,844 to €3,748
- Financial charges -€39,126
down €39,126 (-98.9%), from €39,564 to €437
- Purchases and services -€10,846
down €10,846 (-88.8%), from €12,207 to €1,361
- Other operating charges +€1,736
up €1,736 (+219%), from €791 to €2,527
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €554,519 | €543,786 | -€10,733 | -1.9% |
| Fixed assets | 21/28 | €541,970 | €531,427 | -€10,543 | -1.9% |
| Tangible fixed assets | 22/27 | €541,970 | €531,427 | -€10,543 | -1.9% |
| Land and buildings | 22 | €541,970 | €531,427 | -€10,543 | -1.9% |
| Current assets | 29/58 | €12,549 | €12,359 | -€190 | -1.5% |
| Amounts receivable within one year | 40/41 | €12,284 | €256 | -€12,028 | -97.9% |
| Trade receivables | 40 | €12,184 | €255 | -€11,929 | -97.9% |
| Other amounts receivable | 41 | €100 | €2 | -€99 | -98.4% |
| Cash at bank and in hand | 54/58 | €265 | €12,103 | +€11,838 | +4,470% |
| Total equity and liabilities | 10/49 | €554,519 | €543,786 | -€10,733 | -1.9% |
| Equity | 10/15 | €93,336 | €78,470 | -€14,867 | -15.9% |
| Contributions | 10/11 | €305,500 | €305,500 | = | 0.0% |
| Capital | 10 | €305,500 | €305,500 | = | 0.0% |
| Issued capital | 100 | €305,500 | €305,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€212,164 | -€227,030 | -€14,867 | -7.0% |
| Amounts payable | 17/49 | €461,183 | €465,317 | +€4,134 | +0.9% |
| Amounts payable within one year | 42/48 | €461,183 | €465,317 | +€4,134 | +0.9% |
| Trade debts | 44 | €1,183 | - | -€1,183 | |
| Suppliers | 440/4 | €1,183 | - | -€1,183 | |
| Other amounts payable | 47/48 | €460,000 | €465,317 | +€5,317 | +1.2% |
| Turnover | 70 | €56,051 | - | -€56,051 | |
| Non-recurring operating income | 76A | - | €5,109 | +€5,109 | |
| Goods, raw materials, services and sundry goods | 60/61 | €12,207 | €1,361 | -€10,846 | -88.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €17,030 | €15,652 | -€1,378 | -8.1% |
| Other operating charges | 640/8 | €791 | €2,527 | +€1,736 | +219% |
| Gross operating margin | 9900 | €43,844 | €3,748 | -€40,096 | -91.5% |
| Operating profit (loss) | 9901 | €26,022 | -€14,431 | -€40,453 | |
| Financial income | 75/76B | - | €2 | +€2 | |
| Recurring financial income | 75 | - | €2 | +€2 | |
| Financial charges | 65/66B | €39,564 | €437 | -€39,126 | -98.9% |
| Recurring financial charges | 65 | €39,564 | €437 | -€39,126 | -98.9% |
| Profit (loss) for the period before taxes | 9903 | -€13,541 | -€14,867 | -€1,325 | -9.8% |
| Profit (loss) for the period | 9904 | -€13,541 | -€14,867 | -€1,325 | -9.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€13,541 | -€14,867 | -€1,325 | -9.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.